A recent study has raised concerns about the long-term use of gabapentin among chronic pain patients. Findings show that individuals who received six or more prescriptions had a 29% increased risk of developing dementia, and those with 12 or more prescriptions faced a 40% higher risk. The risk was most pronounced in adults aged 35 to 49. While the study identifies a correlation—not causation—medical experts urge healthcare providers to monitor cognitive health in patients using gabapentin for extended periods. The researchers emphasize that more studies are needed to fully understand the relationship. Meanwhile, patients are strongly advised not to stop taking gabapentin without consulting their doctor, as abrupt discontinuation can lead to serious withdrawal symptoms or worsening of their condition. The study has sparked conversation among medical professionals about balancing effective pain management with long-term cognitive health risks. As awareness grows, the findings may prompt revised prescribing guidelines and increased monitoring for patients, especially those in higher-risk age groups. Ultimately, personal safety and informed medical guidance remain key in managing chronic pain and medication use.
